Revvity Inc. $RVTY Shares Bought by Perbak Capital Partners LLP

Perbak Capital Partners LLP boosted its holdings in shares of Revvity Inc. (NYSE:RVTY) by 191.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 16,545 shares of the company’s stock after purchasing an additional 10,877 shares during the quarter. Perbak Capital Partners LLP’s holdings in Revvity were worth $1,450,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. AQR Capital Management LLC increased its stake in shares of Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC lifted its position in Revvity by 102.0% during the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after purchasing an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth grew its position in Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after purchasing an additional 811 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Trading Up 1.0%

Shares of RVTY stock opened at $85.60 on Friday. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $118.30. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. The stock’s fifty day moving average is $102.27 and its two-hundred day moving average is $96.50. The firm has a market capitalization of $9.57 billion, a P/E ratio of 41.15, a PEG ratio of 1.80 and a beta of 1.10.

Revvity (NYSE:RVTY) last released its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. The business had revenue of $772.06 million during the quarter, compared to analyst estimates of $759.81 million. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Research analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is presently 13.46%.

Analyst Ratings Changes

A number of equities analysts have weighed in on RVTY shares. Jefferies Financial Group lifted their price objective on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Evercore raised their target price on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Barclays lifted their price target on Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Tuesday, February 3rd. TD Cowen reissued a “hold” rating on shares of Revvity in a report on Tuesday, February 3rd. Finally, Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, February 26th. Five investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Revvity has a consensus rating of “Hold” and a consensus target price of $113.67.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.